Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence

A growing body of evidence suggests that the gut microbiota contributes to the development of neurodegenerative diseases via the microbiota-gut-brain axis. As a contributing factor, microbiota dysbiosis always occurs in pathological changes of neurodegenerative diseases, such as Alzheimer’s disease,...

Full description

Saved in:
Bibliographic Details
Published inNeural regeneration research Vol. 19; no. 4; pp. 833 - 845
Main Authors Liu, Xiaoyan, Liu, Yi, Liu, Junlin, Zhang, Hantao, Shan, Chaofan, Guo, Yinglu, Gong, Xun, Cui, Mengmeng, Li, Xiubin, Tang, Min
Format Journal Article
LanguageEnglish
Published India Medknow Publications & Media Pvt. Ltd 01.04.2024
School of Life Sciences,Jiangsu University,Zhenjiang,Jiangsu Province,China%School of Life Sciences,Jiangsu University,Zhenjiang,Jiangsu Province,China
Institute of Animal Husbandry,Jiangsu Academy of Agricultural Sciences,Nanjing,Jiangsu Province,China%Department of Rheumatology & Immunology,Affiliated Hospital of Jiangsu University,Zhenjiang,Jiangsu Province,China%Department of Neurology,The Second Affiliated Hospital of Shandong First Medical University,Taian,Shandong Province,China
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A growing body of evidence suggests that the gut microbiota contributes to the development of neurodegenerative diseases via the microbiota-gut-brain axis. As a contributing factor, microbiota dysbiosis always occurs in pathological changes of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. High-throughput sequencing technology has helped to reveal that the bidirectional communication between the central nervous system and the enteric nervous system is facilitated by the microbiota’s diverse microorganisms, and for both neuroimmune and neuroendocrine systems. Here, we summarize the bioinformatics analysis and wet-biology validation for the gut metagenomics in neurodegenerative diseases, with an emphasis on multi-omics studies and the gut virome. The pathogen-associated signaling biomarkers for identifying brain disorders and potential therapeutic targets are also elucidated. Finally, we discuss the role of diet, prebiotics, probiotics, postbiotics and exercise interventions in remodeling the microbiome and reducing the symptoms of neurodegenerative diseases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1673-5374
1876-7958
DOI:10.4103/1673-5374.382223